李嘉誠基金會:首批送予香港醫護N95到港 即將送給醫管局
李嘉誠基金會早前公布,為支援香港醫護前線,不斷努力在各地採購和物色合乎標準的物資,而基金會一直與醫管局作出緊密溝通,確保捐贈物資符合規格及適用,本周起從加拿大戴爾豪斯大學(Dalhousie University)微生物與免疫學院助購的高規格防護衣及阿聯酋贈送的N95醫療口罩,將陸續運抵香港,並按醫管局統籌向醫護前線送上。
基金會今日中午於社交網站發文,指首批送予香港醫護的N95口罩已到港,即將送給醫管局,帖文圖片所見口罩由3M生產,數量最少有84箱。(el/u) ~
阿思達克財經新聞
網址: www.aastocks.com
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.